Skip to main content
. 2020 Jul 6;10:11115. doi: 10.1038/s41598-020-68037-8

Table 2.

Percentage of cohort eliminated by trimming to 0.25–0.75 preference score.

Data source Alendronate (%) Raloxifene (%) Total (%)
P-Plus 10 11 10
Optum CEDM 7.20 5.90 7
Truven CCAE 3.40 3.80 3.40
Truven MDCR 5.80 6.50 5.90
NHIS NSC 12 17 13
Truven MDCD 7.90 14.00 8.40
Cerner UT 21 19 21
Columbia 0 0 0
Stanford 0 0 0